ash111, I understand and agree with most of what you said, that's why I like the company.
But that doesn't mean an investor can't protect SOME of their HUGE profits.
I know about TPIV's "potential", how many biotech's did GREAT in phase 1 and then failed down the road? A TON. All I'm saying is your up 500%, protect some profits.
The endpoints for phase 1 are generally about dosage levels, not how many people did we cure. I read about "Robust Immune Responses", that's not we cured anybody, it's not tumor shrinkage, it's not progression free survival rates, it's a Phase 1 trial, it's not written in stone yet.
Again, I like the company, but when a stock (TPIV or any other) is up 500% in a month, I also like protecting SOME profits.
Yes, the phase 1 was encouraging .... but I'm not sure I would use the word "validates" the technology yet. What you normally validate in phase 1 is dosage levels.
I wasn't comparing TPIV to Blue or Juno as far as their financing is concerned or anything else other than when your stock is up 200% to 600%, you should Protect Some Profits.
ash, we both own RXII, when it's up 300% to 500%, I'm putting a stop loss in for half my shares.
That's all I'm saying, you KNOW there will be profit taking, why ride it back down, take some profit and buy it back cheaper.
If you never get the chance to buy it back cheaper, oh well, you still own half your shares for free.
I'm not disagreeing with you about TPIV, I like it, I also like turning paper profits in to real money, that's all
News 
Market Data 
Discover 
